One-year consolidation with Ponatinib 15 mg in chronic myeloid leukaemia on deep molecular response with Imatinib. [PDF]
Pérez-Lamas L +20 more
europepmc +1 more source
Changes in hepatic and renal Doppler ultrasonography: Current standard therapy in dogs with congestive heart failure. [PDF]
Esin Ç, Güzel M.
europepmc +1 more source
A Comment on the use of Levosimendan for the Management of Right Ventricular Dysfunction in Patients Undergoing Mitral Valve Surgery. [PDF]
Shah D, Korfiotis D, Zimbler N.
europepmc +1 more source
Remarkable pathological response to neoadjuvant tepotinib in lung adenocarcinoma with MET exon 14 skipping mutation: A case report. [PDF]
Li R +7 more
europepmc +1 more source
Exploring the Allosteric Pathways of Asciminib in the Dual Inhibition of BCR-ABL1. [PDF]
Ming J, Gao H, Zhan J.
europepmc +1 more source
Real-world safety of Tepotinib: Insights from the Food and Drug Administration Adverse Event Reporting System. [PDF]
Wei S, Zhang L, Liu C, Qi X.
europepmc +1 more source
Efficacy, safety and predictive biomarker of third-generation tyrosine kinase inhibitors with azacitidine in myeloid blast phase of chronic myeloid leukemia. [PDF]
Bao M +9 more
europepmc +1 more source
Unexpected Tellurohalogenation of Terminal N-Alkynyl (Alkenyl) Derivatives of 4-Functionalized Pyrazoles. [PDF]
Povidaichyk MV +3 more
europepmc +1 more source

